# Karyopharm Therapeutics

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/karyopharm-therapeutics/

## Facts

| Field | Value |
| --- | --- |
| Country | US |
| Description | company in Newton, United States |
| OpenAlex ID | https://openalex.org/F4320309542 |
| ROR ID | https://ror.org/04ty78924 |
| Works | 736 |

## Funder papers

- [Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer](https://scholariq.org/papers/niraparib-in-patients-with-newly-diagnosed-advanced-ovarian-cancer/)
- [Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial](https://scholariq.org/papers/niraparib-first-line-maintenance-therapy-in-patients-with-newly-diagnosed/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.